Inventor · disambiguated record
Ming C. Yeung
Also filed as: YEUNG MING C · YEUNG MING CLINTON · YEUNG Ming
30 granted patents·17 pending applications·240 citations·filing 1996–2021
96Inventor score
Top patents by PatentIndex Score
47 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0392US7517876B2Anti-infective agentsABBOTT LAB·Filed 2006·Granted Apr 14, 2009·13 cites·19 claims
- 0491US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0591US6455571B1Inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Sep 24, 2002·60 cites·115 claims
- 0685US7378414B2Anti-infective agentsABBOTT LAB·Filed 2004·Granted May 27, 2008·17 cites·30 claims
- 0784US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 0882US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 0981US9567322B2Substituted tetrahydropyrans and method of useABBVIE S Á R L·Filed 2015·Granted Feb 14, 2017·4 cites·98 claims
- 1079US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 1179US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 1276US8129417B2Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockersSTEWART ANDREW O·Filed 2009·Granted Mar 6, 2012·6 cites·20 claims
- 1373US8937041B2Macrocyclic hepatitis C serine protease inhibitorsMCDANIEL KEITH F·Filed 2011·Granted Jan 20, 2015·2 cites·18 claims
- 1473US8691865B2Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockersSEARLE XENIA B·Filed 2011·Granted Apr 8, 2014·4 cites·23 claims
- 1572US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 1671US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1771US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1871US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 1970US5696084AAmino-lipopetide antifungal agentsABBOTT LAB·Filed 1996·Granted Dec 9, 1997·37 cites·16 claims
- 2069US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 2169US6831096B2Inhibitors of neuraminidasesABBOTT LAB·Filed 2002·Granted Dec 14, 2004·3 cites·9 claims
- 2268US2014243340A1Cytochrome p450 oxidase inhibitors and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 2366US2008161246A1Cytochrome P450 Oxidase Inhibitors and Uses ThereofABBOTT LAB·Filed 2007·Application pending·0 cites
- 2464US2013131085A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2012·Application pending·0 cites
- 2563US2012309762A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2012·Application pending·0 cites
- 2663US2014194349A1HIV Protease Inhibiting CompoundsABBVIE INC·Filed 2014·Application pending·0 cites
- 2763US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 2862US5789591AProcess for preparing 1-substituted 8-chloro-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester compoundsABBOTT LAB·Filed 1996·Granted Aug 4, 1998·9 cites·8 claims
- 2961US7696226B2HIV protease inhibiting compoundsABBOTT LAB·Filed 2004·Granted Apr 13, 2010·1 cites·49 claims
- 3061US2012083490A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2011·Application pending·0 cites
- 3160US7834043B2HIV protease inhibiting compoundsABBOTT LAB·Filed 2004·Granted Nov 16, 2010·1 cites·9 claims
- 3260US2017190693A1Substituted chromanes and method of useABBVIE S À R L·Filed 2017·Application pending·0 cites
- 3359US8497275B2HCV protease inhibitors and uses thereofGREEN BRIAN E·Filed 2009·Granted Jul 30, 2013·0 cites·14 claims
- 3457US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 3556US2013303547A1HCV Protease Inhibitors and Uses ThereofABBVIE INC·Filed 2013·Application pending·0 cites
- 3655US7538105B2Anti-infective agentsABBOTT LAB·Filed 2008·Granted May 26, 2009·0 cites·19 claims
- 3755US6518305B1Five-membered carbocyclic and heterocyclic inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Feb 11, 2003·6 cites·110 claims
- 3855US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 3954US8653141B2HIV protease inhibiting compoundsFLENTGE CHARLES A·Filed 2012·Granted Feb 18, 2014·0 cites·31 claims
- 4054US2018037587A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2017·Application pending·0 cites
- 4153US2005131042A1HIV protease inhibiting compoundsFiled 2003·Application pending·0 cites
- 4253US2010249181A1HIV Protease Inhibiting CompoundsABBOTT LAB·Filed 2010·Application pending·0 cites
- 4353US2019315687A1Substituted Pyrrolidines and Methods of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 4449US8193227B2HIV protease inhibiting compoundsFLENTGE CHARLES A·Filed 2004·Granted Jun 5, 2012·0 cites·19 claims
- 4548US2015119319A1Macrocyclic hepatitis c serine protease inhibitorsABBOTT LAB·Filed 2015·Application pending·0 cites
- 4641US7902203B2Anti-infective agentsABBOTT LAB·Filed 2003·Granted Mar 8, 2011·0 cites·23 claims
- 4736US8796470B2Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulatorsSEARLE XENIA B·Filed 2011·Granted Aug 5, 2014·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →